TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1

CUSIP: 88165UAB5

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Debt / NOTE 8.000% 6/1
Market price (% of par)
16.11%
Total 13F principal
$44,336,000
Principal change
$0
Total reported market value
$7,261,000
Number of holders
10
Value change
-$294,000
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 88165UAB5?
CUSIP 88165UAB5 identifies 88165UAB5 - TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 as of Q2 2016

As of 30 Jun 2016, TETRALOGIC PHARMACEUTICALS C - NOTE 8.000% 6/1 was held by 10 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $44,336,000 in principal (par value) of the bond. The largest 10 bondholders included WHITEBOX ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, Linden Advisors LP, Cormorant Asset Management, LLC, NOMURA HOLDINGS INC, Telemetry Investments, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Hudson Bay Capital Management LP, and CREDIT AGRICOLE S A. This page lists 10 institutional bondholders reporting positions for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.